Sheldon L. Koenig - Net Worth and Insider Trading
Sheldon L. Koenig Net Worth
The estimated net worth of Sheldon L. Koenig is at least $685,067 dollars as of 2024-05-11. Sheldon L. Koenig is the President and CEO of Esperion Therapeutics Inc and owns about 312,816 shares of Esperion Therapeutics Inc (ESPR) stock worth over $685,067. Details can be seen in Sheldon L. Koenig's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sheldon L. Koenig has not made any transactions after 2023-05-09 and currently still holds the listed stock(s).
Transaction Summary of Sheldon L. Koenig
Sheldon L. Koenig Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sheldon L. Koenig owns 1 companies in total, including Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Sheldon L. Koenig’s form 4 insider trades.
Insider Ownership Summary of Sheldon L. Koenig
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2023-05-09 | Chief Operating Officer |
Sheldon L. Koenig Latest Holdings Summary
Sheldon L. Koenig currently owns a total of 1 stock. Sheldon L. Koenig owns 312,816 shares of Esperion Therapeutics Inc (ESPR) as of May 9, 2023, with a value of $685,067.
Latest Holdings of Sheldon L. Koenig
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2023-05-09 | 312,816 | 2.19 | 685,067 |
Holding Weightings of Sheldon L. Koenig
Sheldon L. Koenig Form 4 Trading Tracker
According to the SEC Form 4 filings, Sheldon L. Koenig has made a total of 7 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 20,000 shares on May 9, 2023, which cost Sheldon L. Koenig around $25,200.
Insider Trading History of Sheldon L. Koenig
- 1
Sheldon L. Koenig Trading Performance
GuruFocus tracks the stock performance after each of Sheldon L. Koenig's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sheldon L. Koenig is 26.15%. GuruFocus also compares Sheldon L. Koenig's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sheldon L. Koenig within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sheldon L. Koenig's insider trading performs compared to the benchmark.
Performance of Sheldon L. Koenig
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.2 | | | | | |
| Relative Return to S&P 500(%) | 10.69 | | | | | |
Sheldon L. Koenig Ownership Network
Sheldon L. Koenig Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Sheldon L. Koenig is the Chief Operating Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Medical Officer Joanne M. Foody , and General Counsel Benjamin Looker .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Sheldon L. Koenig made 3 insider transaction in Esperion Therapeutics Inc (ESPR) with a net purchase of 7,560. Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,644 shares made by Eric Warren , a net sale of 9,821 shares made by Joanne M. Foody , and a net sale of 7,637 shares made by Benjamin Looker .
In summary, during the past 3 months, insiders sold 0 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,542 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 22,069 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Sheldon L. Koenig Mailing Address
Above is the net worth, insider trading, and ownership report for Sheldon L. Koenig. You might contact Sheldon L. Koenig via mailing address: C/o Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
